Exponent Crescita futura
Criteri Future verificati 2/6
Exponent prevede che gli utili e i ricavi cresceranno rispettivamente di 8.4% e 7.9% all'anno. Si prevede che l'EPS crescerà di 8.9% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 29.7% in 3 anni.
Informazioni chiave
8.4%
Tasso di crescita degli utili
8.90%
Tasso di crescita dell'EPS
| Professional Services crescita degli utili | 15.5% |
| Tasso di crescita dei ricavi | 7.9% |
| Rendimento futuro del capitale proprio | 29.71% |
| Copertura analitica | Low |
| Ultimo aggiornamento | 01 May 2026 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Seeking Alpha • May 04
Exponent: Rising Demand And A Reasonable Valuation Make It A Buy
Summary Exponent is a market leader in scientific and engineering consulting, boasting a 13-year dividend growth streak and a fortress balance sheet. EXPO’s fiscal 2026 outlook signals rising top and bottom lines, with AI-related demand driving proactive and reactive service growth. The stock trades at ~26.5x FY26E EPS, well below its 5-year average, suggesting undervaluation with a fair value estimate of $73.80 versus a ~$65 share price. Dividend safety is outstanding, supported by a conservative ~50% payout ratio, robust free cash flow, and no debt. Read the full article on Seeking Alpha
Aggiornamento dell'analisi • May 03
EXPO: AI Failure Analysis And Buybacks Will Support Higher Earnings Quality
Analysts have adjusted their view on Exponent with a modest change to the price target in the $5 range, reflecting updated assumptions on growth, profitability and a slightly higher future P/E multiple informed by recent mixed revisions from JPMorgan and UBS. Analyst Commentary Recent commentary around Exponent highlights a mix of caution and optimism, with price targets adjusted within a narrow range and opinions split on the risk and reward at current levels.Aggiornamento dell'analisi • Apr 18
EXPO: AI Failure Analysis Demand Will Support Higher Earnings Quality
Analysts have adjusted the 12 month price target on Exponent to $95 from $90, reflecting updated assumptions around revenue growth, profit margins, and the P/E multiple they are willing to apply to future earnings. Analyst Commentary Recent Street research on Exponent has centered on how much investors are willing to pay for the company’s future earnings, with price targets adjusted as analysts revisit revenue assumptions, profit margins, and the P/E multiple.
Aggiornamento dell'analisi • Apr 04
EXPO: AI Failure Analysis Work Will Sustain Premium P/E And Shareholder Returns
Analysts have trimmed their average price target for Exponent by $1.67 to reflect slightly lower fair value and profit margin assumptions, while still applying a relatively high future P/E multiple informed by recent mixed price target moves from JPMorgan and UBS. Analyst Commentary Recent Street research on Exponent reflects a mix of optimism about the business model and caution around valuation and near term execution, which is why price targets have moved in both directions.Aggiornamento dell'analisi • Mar 21
EXPO: AI Failure Analysis Work Will Support Margins And Shareholder Returns
Analysts have lifted their 12 month price target on Exponent by about $6 to around $92. This reflects updated expectations around revenue, margins and a slightly lower future P/E multiple following recent research updates from major firms.
Aggiornamento dell'analisi • Mar 07
EXPO: Buybacks And Dividend Increases Will Support Future Shareholder Returns
Analysts nudged their price target on Exponent higher by $4, citing slightly firmer growth and margin assumptions, along with a modestly lower future P/E outlook as key supports for the revised view. Analyst Commentary Recent research coverage around Exponent has centered on how much investors should be willing to pay for the company relative to its growth and margin profile.Aggiornamento dell'analisi • Feb 20
EXPO: Raised UBS Target And Buybacks Will Support Higher Future P/E
Analysts have raised their price target on Exponent by $4 to $85, citing updated assumptions that include slightly lower revenue growth, a modestly higher discount rate, improved profit margin expectations, and a higher future P/E multiple. Analyst Commentary Recent Street research around Exponent highlights a mix of optimism and restraint, with the latest published work focusing on valuation inputs, growth expectations, and how much investors are willing to pay for the stock through the P/E multiple.Articolo di analisi • Feb 09
Exponent (NASDAQ:EXPO) Is Increasing Its Dividend To $0.31
The board of Exponent, Inc. ( NASDAQ:EXPO ) has announced that the dividend on 20th of March will be increased to...Aggiornamento dell'analisi • Feb 06
EXPO: Bullish JPMorgan Initiation Will Support Confidence In Updated Fair Value Estimate
Analysts have raised their fair value estimate for Exponent from US$76.00 to US$81.00, citing updated assumptions for revenue growth, profit margins, and a slightly lower future P/E multiple in light of recent bullish Street research. Analyst Commentary Recent Street research, including a new bullish view from JPMorgan, has put more attention on how Exponent is priced and what could get in the way of the updated fair value estimate of US$81.00.Aggiornamento dell'analisi • Jan 23
EXPO: AI Failure Analysis Work Will Offset Automation Headwind Risks
Analysts have trimmed their price target on Exponent to US$90 from US$100, citing both the potential for increased AI driven failure analysis work and the offsetting risk that greater automation could reduce billable hours in consulting. Analyst Commentary Recent research points to a more balanced view on Exponent, with the reduced US$90 price target reflecting both potential upside from AI driven work and execution risks around automation in core consulting practices.Aggiornamento dell'analisi • Jan 09
EXPO: AI Failure Analysis Demand Will Support Future Consulting Engagements
Analysts have reduced their fair value estimate for Exponent to $90 from $100, citing a lower assumed future P/E multiple as they weigh the potential for AI-driven demand for failure analysis work against the risk that automation could reduce billable hours across the consulting sector. Analyst Commentary Recent commentary from bullish analysts centers on how AI adoption could shape Exponent's long term opportunity set, even as they factor in the risk that automation may cap billable hours across the consulting sector.Articolo di analisi • Jan 08
What Exponent, Inc.'s (NASDAQ:EXPO) P/E Is Not Telling You
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 34.9x might make it look like a strong sell...Aggiornamento dell'analisi • Dec 16
EXPO: AI Failure Analysis Demand Will Outweigh Automation Efficiency Headwinds
Analysts have nudged their fair value estimate for Exponent higher to approximately $85.50 from $83.00 per share, citing the potential for AI driven demand in complex failure analysis work, while acknowledging that automation related efficiency gains could temper billable hours across the consulting industry. Analyst Commentary Bullish analysts highlight that the revised target still implies meaningful upside from current levels, even after a modest trim.Aggiornamento dell'analisi • Dec 01
EXPO: AI-Driven Demand Will Drive Future Engagements Despite Automation Headwinds
Analysts have revised Exponent's price target downward by $10 to $90 per share, citing potential opportunities from AI-driven engagements as well as industry headwinds related to automation efficiencies. Analyst Commentary Following the recent revision to Exponent's price target, analysts have highlighted both opportunities and risks facing the company in today's evolving market landscape.Aggiornamento dell'analisi • Nov 17
EXPO: AI-Driven Client Demand Will Offset Automation Concerns In Consulting
Exponent’s analyst price target has been reduced by $10 to $90, as analysts cite ongoing automation concerns that could impact the consulting sector. They also note potential opportunities from increased AI-driven client demand.Articolo di analisi • Nov 02
Exponent, Inc. Just Beat EPS By 8.5%: Here's What Analysts Think Will Happen Next
A week ago, Exponent, Inc. ( NASDAQ:EXPO ) came out with a strong set of third-quarter numbers that could potentially...Aggiornamento dell'analisi • Nov 02
EXPO: Increased Buyback Will Drive Shareholder Returns In Coming Quarters
Narrative Update: Exponent Analyst Price Target Adjustment Analysts have lowered their price target for Exponent from $88 to $83. This change reflects updated expectations for revenue growth and profitability margins moving forward.Articolo di analisi • Oct 06
Returns On Capital At Exponent (NASDAQ:EXPO) Have Stalled
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...Articolo di analisi • Jul 30
A Look At The Fair Value Of Exponent, Inc. (NASDAQ:EXPO)
Key Insights Exponent's estimated fair value is US$63.97 based on 2 Stage Free Cash Flow to Equity Exponent's US$70.44...Articolo di analisi • Jul 14
When Should You Buy Exponent, Inc. (NASDAQ:EXPO)?
Exponent, Inc. ( NASDAQ:EXPO ), might not be a large cap stock, but it received a lot of attention from a substantial...Articolo di analisi • Jun 28
Exponent (NASDAQ:EXPO) Knows How To Allocate Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Articolo di analisi • May 27
Subdued Growth No Barrier To Exponent, Inc.'s (NASDAQ:EXPO) Price
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 36.7x might make it look like a strong sell...Articolo di analisi • Apr 06
Is Exponent, Inc. (NASDAQ:EXPO) Potentially Undervalued?
Exponent, Inc. ( NASDAQ:EXPO ), might not be a large cap stock, but it saw significant share price movement during...Articolo di analisi • Mar 22
Return Trends At Exponent (NASDAQ:EXPO) Aren't Appealing
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Seeking Alpha • Mar 10
Exponent: A Unique Dividend Contender That Is Valued At A Premium
Summary Exponent Inc. is a market leader in scientific and engineering consulting, with a 13-year dividend growth streak and a solid balance sheet. Despite strong revenue and earnings growth, the valuation is at a premium, making Exponent a hold. The company's competitive advantages include its reputation, technical expertise, and long-term client relationships, ensuring continued market leadership. Exponent's dividend safety is excellent, supported by a conservative payout ratio and robust free cash flow, but the current valuation is a concern. Read the full article on Seeking AlphaArticolo di analisi • Feb 13
Exponent's (NASDAQ:EXPO) Shareholders Will Receive A Bigger Dividend Than Last Year
Exponent, Inc.'s ( NASDAQ:EXPO ) dividend will be increasing from last year's payment of the same period to $0.30 on...Articolo di analisi • Jan 30
Exponent, Inc.'s (NASDAQ:EXPO) Intrinsic Value Is Potentially 34% Above Its Share Price
Key Insights The projected fair value for Exponent is US$122 based on 2 Stage Free Cash Flow to Equity Exponent is...Articolo di analisi • Dec 28
Risks To Shareholder Returns Are Elevated At These Prices For Exponent, Inc. (NASDAQ:EXPO)
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 42.7x might make it look like a strong sell...Articolo di analisi • Dec 10
Here's What To Make Of Exponent's (NASDAQ:EXPO) Decelerating Rates Of Return
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Articolo di analisi • Nov 08
Exponent's (NASDAQ:EXPO) Earnings Seem To Be Promising
Despite posting healthy earnings, Exponent, Inc.'s ( NASDAQ:EXPO ) stock has been quite weak. Along with the solid...Articolo di analisi • Oct 13
Estimating The Intrinsic Value Of Exponent, Inc. (NASDAQ:EXPO)
Key Insights Exponent's estimated fair value is US$114 based on 2 Stage Free Cash Flow to Equity Current share price of...
Nuova analisi • Aug 29
Operational Efficiency And Tactical Investments Set To Propel Future Profitability And Revenue Growth
Exponent's strategic management and operational efficiency improvements are poised to enhance future profitability and earnings potential.Articolo di analisi • Aug 20
Exponent, Inc.'s (NASDAQ:EXPO) Share Price Not Quite Adding Up
Exponent, Inc.'s ( NASDAQ:EXPO ) price-to-earnings (or "P/E") ratio of 51.1x might make it look like a strong sell...Articolo di analisi • Jul 28
Exponent, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
As you might know, Exponent, Inc. ( NASDAQ:EXPO ) recently reported its second-quarter numbers. Revenues were US$132m...Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Utili | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2028 | 667 | 138 | N/A | N/A | 1 |
| 12/31/2027 | 648 | 125 | 209 | 173 | 4 |
| 12/31/2026 | 597 | 113 | 185 | 144 | 4 |
| 4/3/2026 | 551 | 109 | 113 | 123 | N/A |
| 1/2/2026 | 537 | 106 | 122 | 132 | N/A |
| 10/3/2025 | 531 | 105 | 123 | 132 | N/A |
| 7/4/2025 | 519 | 103 | 121 | 129 | N/A |
| 4/4/2025 | 519 | 106 | 134 | 141 | N/A |
| 1/3/2025 | 518 | 109 | 138 | 145 | N/A |
| 9/27/2024 | 509 | 106 | 154 | 160 | N/A |
| 6/28/2024 | 508 | 105 | 144 | 152 | N/A |
| 3/29/2024 | 506 | 101 | 132 | 144 | N/A |
| 12/29/2023 | 497 | 100 | 111 | 127 | N/A |
| 9/29/2023 | 496 | 102 | 79 | 97 | N/A |
| 6/30/2023 | 486 | 102 | 87 | 104 | N/A |
| 3/31/2023 | 475 | 102 | 78 | 93 | N/A |
| 12/30/2022 | 464 | 102 | 82 | 94 | N/A |
| 9/30/2022 | 456 | 100 | 97 | 107 | N/A |
| 7/1/2022 | 449 | 100 | 94 | 103 | N/A |
| 4/1/2022 | 443 | 100 | 110 | 117 | N/A |
| 12/31/2021 | 435 | 101 | 118 | 125 | N/A |
| 10/1/2021 | 428 | 103 | 105 | 111 | N/A |
| 7/2/2021 | 413 | 96 | 108 | 115 | N/A |
| 4/2/2021 | 388 | 87 | 112 | 118 | N/A |
| 1/1/2021 | 378 | 83 | 98 | 103 | N/A |
| 10/2/2020 | 383 | 80 | 108 | 118 | N/A |
| 7/3/2020 | 385 | 81 | 104 | 117 | N/A |
| 4/3/2020 | 398 | 86 | 88 | 106 | N/A |
| 1/3/2020 | 391 | 82 | N/A | 108 | N/A |
| 9/27/2019 | 374 | 79 | N/A | 97 | N/A |
| 6/28/2019 | 368 | 77 | N/A | 88 | N/A |
| 3/29/2019 | 357 | 75 | N/A | 75 | N/A |
| 12/28/2018 | 355 | 72 | N/A | 91 | N/A |
| 9/28/2018 | 352 | 53 | N/A | 88 | N/A |
| 6/29/2018 | 346 | 50 | N/A | 79 | N/A |
| 3/30/2018 | 340 | 45 | N/A | 73 | N/A |
| 12/29/2017 | 330 | 41 | N/A | 68 | N/A |
| 9/29/2017 | 320 | 55 | N/A | 57 | N/A |
| 6/30/2017 | 312 | 52 | N/A | 70 | N/A |
| 3/31/2017 | 301 | 49 | N/A | 65 | N/A |
| 12/30/2016 | 299 | 47 | N/A | 67 | N/A |
| 9/30/2016 | 296 | 47 | N/A | 63 | N/A |
| 7/1/2016 | 297 | 47 | N/A | 60 | N/A |
| 4/1/2016 | 299 | 49 | N/A | 59 | N/A |
| 1/1/2016 | 296 | 44 | N/A | 60 | N/A |
| 10/2/2015 | 296 | 43 | N/A | 56 | N/A |
| 7/3/2015 | 295 | 42 | N/A | 52 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: La crescita prevista degli utili di EXPO ( 8.4% all'anno) è superiore al tasso di risparmio ( 3.5% ).
Guadagni vs Mercato: Si prevede che gli utili di EXPO ( 8.4% all'anno) cresceranno più lentamente rispetto al mercato US ( 16.7% all'anno).
Guadagni ad alta crescita: Si prevede che gli utili di EXPO cresceranno, ma non in modo significativo.
Ricavi vs Mercato: Si prevede che il fatturato di EXPO ( 7.9% all'anno) crescerà più lentamente rispetto al mercato US ( 11.6% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di EXPO ( 7.9% all'anno) crescerà più lentamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Si prevede che il Return on Equity di EXPO sarà elevato tra 3 anni ( 29.7 %)
Scoprire le aziende in crescita
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/11 01:17 |
| Prezzo dell'azione a fine giornata | 2026/05/11 00:00 |
| Utili | 2026/04/03 |
| Utili annuali | 2026/01/02 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Exponent, Inc. è coperta da 7 analisti. 4 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Joseph Foresi | Brean Capital Historical (Janney Montgomery) |
| Alexis Huseby | D.A. Davidson & Co. |
| Tomohiko Sano | J.P. Morgan |